Precision Targeted Cancer Therapy Testing - NTRK Gene Fusion Comprehensive Testing

A comprehensive molecular analysis detecting NTRK gene fusions in tumor cells. This test serves as a critical biomarker to identify patients eligible for modern TRK inhibitor therapies, offering personalized treatment options.